These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31384369)

  • 1. The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes.
    Jacobs V; T May H; L Bair T; G Crandall B; J Cutler DO M; D Day J; Le V; Mallender C; S Osborn J; Weiss JP; Bunch TJ
    J Atr Fibrillation; 2019 Apr; 11(6):2164. PubMed ID: 31384369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of anticoagulation strategy after left atrial appendage occlusion in patients requiring direct current cardioversion.
    Maarse M; Wintgens LIS; Ponomarenko A; Phillips KP; Romanov AB; Ballesteros G; Swaans MJ; Folkeringa RJ; Garcia-Bolao I; Boersma LVA
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):737-744. PubMed ID: 33448508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation.
    Meng XS; Chen T; Wang XY; Lu X; Hu J; Shen J; Guo J
    Front Cardiovasc Med; 2023; 10():1219611. PubMed ID: 37745133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
    Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
    J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of dual external direct current cardioversion for initial cardioversion in atrial fibrillation.
    Gardner MW; Yadava M; Raitt MH; Elman MR; Zarraga IG; MacMurdy KS; Dalouk KA; Jessel PM
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1636-1643. PubMed ID: 31111594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes.
    Arya A; Silberbauer JS; Vrahimides J; Cheek E; Mitchell A; Boodhoo L; Pugh P; Large J; Bordoli G; Taggu W; Lloyd GW; Patel NR; Sulke AN
    Int J Clin Pract; 2010 Jul; 64(8):1062-8. PubMed ID: 20642706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease.
    Ammash NM; Phillips SD; Hodge DO; Connolly HM; Grogan MA; Friedman PA; Warnes CA; Asirvatham SJ
    Int J Cardiol; 2012 Feb; 154(3):270-4. PubMed ID: 20934227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.
    Yadlapati A; Groh C; Passman R
    Am J Cardiol; 2014 Apr; 113(8):1362-3. PubMed ID: 24576547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early direct current cardioversion or ablation for atrial fibrillation or atrial flutter and acute decompensated heart failure.
    Foo FS; Kerr A; Gabriel R; Heaven D; Looi JL; Lund M; Voss J; Sutton T
    N Z Med J; 2019 Jun; 132(1496):39-46. PubMed ID: 31170132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality, stroke, and heart failure in atrial fibrillation cohorts after ablation versus propensity-matched cohorts.
    Jarman JW; Hunter TD; Hussain W; March JL; Wong T; Markides V
    Pragmat Obs Res; 2017; 8():99-106. PubMed ID: 28615986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phased RF ablation in persistent atrial fibrillation.
    Hummel J; Michaud G; Hoyt R; DeLurgio D; Rasekh A; Kusumoto F; Giudici M; Dan D; Tschopp D; Calkins H; Boersma L;
    Heart Rhythm; 2014 Feb; 11(2):202-9. PubMed ID: 24239841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation.
    Soran H; Banerjee M; Mohamad JB; Adam S; Ho JH; Ismaeel SM; Dhage S; Syed AA; Abdulla IMA; Younis N; Malik RA
    Biomed Res Int; 2018; 2018():5936180. PubMed ID: 29721508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.
    Sharma SP; Turagam MK; Gopinathannair R; Reddy V; Kar S; Mohanty S; Cheng J; Holmes DR; Sondergaard L; Natale A; Lakkireddy D
    J Am Coll Cardiol; 2019 Nov; 74(18):2267-2274. PubMed ID: 31672183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Catheter Ablation for Atrial Arrhythmias on Repeat Cardioversion in Adults With Congenital Heart Disease.
    Kawada S; Joens C; Chakraborty P; Oechslin EN; Roche SL; Silversides C; Wald RM; Downar E; Harris L; Swan L; Alonso-Gonzalez R; Thorne S; Nanthakumar K; Mondésert B; Khairy P; Nair K
    Can J Cardiol; 2021 Aug; 37(8):1181-1190. PubMed ID: 33246004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes.
    Bunch TJ; May HT; Bair TL; Johnson DL; Weiss JP; Crandall BG; Osborn JS; Anderson JL; Muhlestein JB; Lappe DL; Day JD
    Heart Rhythm; 2013 Sep; 10(9):1257-62. PubMed ID: 23702238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Treatment Outcomes of Arrhythmias in Patients with Single Ventricle Physiology over the Age of 40 Years.
    Pujol C; Hessling G; Telishevska M; Schiele S; Deisenhofer I; Ewert P; Tutarel O
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion.
    Luong C; Thompson DJ; Bennett M; Gin K; Jue J; Barnes ME; Colley P; Tsang TS
    Can J Cardiol; 2015 Jan; 31(1):29-35. PubMed ID: 25547547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation.
    Rochlani YM; Shah NN; Pothineni NV; Paydak H
    Cardiol Res Pract; 2016; 2016():8956020. PubMed ID: 26966608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction.
    Bunch TJ; May HT; Bair TL; Jacobs V; Crandall BG; Cutler M; Weiss JP; Mallender C; Osborn JS; Anderson JL; Day JD
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):363-370. PubMed ID: 25534572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre.
    Sharif Z; Srinivas B; Tiedt I; Ryan N; Awadalla M; Sullivan V; Foley DP; Gumbrielle T; McAdam B; Sheahan RG
    Ir J Med Sci; 2017 Aug; 186(3):615-620. PubMed ID: 28233168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.